Medcura

Medcura, Inc.

174 Investors

Medical Devices and Biotechnology

RIVERDALE, MD

Medcura, Inc. is a commercial-stage medical device company that develops and commercializes innovative hemostatic products to control bleeding across various applications. Utilizing a proprietary biopolymer technology platform, the company creates cost-effective solutions for surgical, medical, and consumer markets. These products are designed to rapidly stop bleeding while providing an antibacterial barrier and promoting healing, addressing critical unmet needs in bleeding management.

Products & Team

LifeGel™

Surgical HemostatSeed

LifeGel™ is an absorbable hemostatic gel and the company's flagship product, designed for use in surgical procedures. It has received FDA Breakthrough Device Designation and is particularly aimed at complex operations like spinal surgery where swelling from traditional hemostats can cause serious complications such as nerve damage.

Value Proposition

LifeGel™ solves the critical problem of postoperative complications caused by the swelling of conventional hemostatic agents in confined surgical spaces, offering a safer and effective alternative.

Pain Points

The company addresses key customer problems including the high cost of existing biosurgery products, the risk of nerve injury and other complications due to swelling from hemostatic agents, and the need for rapid, effective bleeding control in both surgical and trauma scenarios.

No-swell formulation to prevent compression of surrounding tissuesRapid and effective bleeding controlCreates an antibacterial barrier at the application siteFully absorbable biopolymer composition